TORONTO, July 7, 2023 /CNW/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”‘)(CSE: CYBT)(OTCQB: CYBCF) is pleased to announce the signing of a licence agreement for SBOM Studio with a global medical device manufacturing (MDM) company, ranking in the top 5 based on revenue.1
This license marks Cybeats’ second commercial agreement with MDM providers from the global top 5. Cybeats also recently announced a pilot evaluation2 with another MDM from the top 5, and the commercial pipeline has expanded to include several MDMs from the global top 20.3
“Securing a contract with another prominent medical device company highlights the increasing demand for SBOM Studio. Our platform offers comprehensive solutions for risk management and supports compliance with the recently mandated FDA requirements, ensuring enhanced cybersecurity for the healthcare industry. We expect that the Healthcare IT and MDM sector will continue to be a significant catalyst for Cybeats’ commercial expansion,”said Bob Lyle, CRO of Cybeats
Cybeats SBOM Studio delivers comprehensive software supply chain intelligence technology, empowering the company to effectively manage…
